CN101716337A

CN101716337A - Liquid medicine for treating dermatophytosis and tinea pedis

Info

Publication number: CN101716337A
Application number: CN200910227425A
Authority: CN
Inventors: 马照芳
Original assignee: Individual
Current assignee: Individual
Priority date: 2009-12-10
Filing date: 2009-12-10
Publication date: 2010-06-02

Abstract

The invention relates to liquid medicine for treating dermatophytosis and tinea pedis, aiming to effectively solve the problem of quick and efficient treatment of dermatophytosis and tinea pedis. A preparation method of the liquid medicine comprises the following step of: uniformly mixing 50-70 percent of active compound amino acid, 25-45 percent of vegetable acid and 3-8 percent of papain in percentage by weight, wherein the active compound amino acid is formed by uniformly mixing aspartic acid, threonine, glutamic acid, glycocoll, alanine, cystine, methionine, isoleucine, leucine, tyrosine, praline, arginine, histidine, lysine, phenylalanine, valine and water; the vegetable acid comprises acetic acid, methanoic acid, propionic acid, methyl alcohol, acetone, 2-furan aldehydes, 2-cyclopentenone, guaiacol, para-cresol, ob-cresol, o-cresol, ethyl guaiacol, furfural, flavone, maltol, vanillin and water; and the papain is papayotin. The only thing needed in the preparation of the liquid medicine is to mixing the components. The liquid medicine has reasonable matching, easy production, low cost and no toxic and side effects and is an innovation for treating the dermatophytosis and the tinea pedis.

Description

A kind of medicinal liquid for the treatment of beriberi, tinea pedis

One, technical field

The present invention relates to medicine, particularly a kind of medicinal liquid for the treatment of beriberi, tinea pedis.

Two, background technology

Beriberi, tinea pedis is a kind of common frdquently encountered disease, have a strong impact on patient's body health and daily life, even influence normal productive labor, working and learning, treat beriberi at present, the medicine of tinea pedis is a lot, as the whitfield ointment package, oral itraconazole, external salicylic acid tincture, clotrimazole, econazole, miconazole frost or liniment etc., but for various reasons, its therapeutic effect is also use up people's will, particularly easily recurrence, and also the cycle is long, trouble, be unfavorable for again sanitary maintenance, as various liniments and ointment, cause unhygienic phenomenon in the middle of the treatment, influence therapeutic effect on the contrary, therefore, the improvement of medicine and innovate imperative.

Three, summary of the invention

At above-mentioned situation, for overcoming the defective of prior art, the present invention's purpose just provides a kind of treatment beriberi, the medicinal liquid of tinea pedis, can effectively solve beriberi, tinea pedis fast, efficient treatment problem, the technical scheme of its solution is, beriberi, tinea pedis common name beriberi, it is foot's disease that a kind of foot is caused by trichophyton mentagrophytes infection, it is ventilative not enough that its inducement mostly is foot, due to sultry humidity and the wound, treatment must be taked sterilization, sterilization, dry diuretic, recover the method for human body, so the present invention adopts weight percent meter: active aminoacids complex 50-70%, plant acid 25-45% is mixed with carase 3-8% and evenly forms together, and said active aminoacids complex is counted the active aminoacids complex of per 100 grams by aspartic acid 0.94 gram by weight, threonine 0.44 gram, glutamic acid 1.96 grams, glycine 1.4 grams, alanine 1.47 grams, cystine 0.56 gram, methionine 0.16 gram, isoleucine 0.72 gram, leucine 1.26 grams, tyrosine 0.12 gram, proline 1.82 grams, arginine 1.12 grams, histidine 0.08 gram, lysine 0.34 gram, phenylalanine 0.74 gram, valine 1.36 grams and surplus are formed for the water mixing; Said plant acid is a weight percent meter: acetic acid 15.6%, formic acid 11.1%, propanoic acid 0.63%, methanol 5.54%, acetone 1.7%, 2-Furan Aldehydes 2.1%, 2-cyclopentenone 0.2%, guaiacol 0.3%, paracresol 1.0%, be that water is formed to cresol 1.4%, orthoresol 1.2%, ethyl guaiacol 0.3%, furfural 0.5%, flavone 0.7%, maltol 0.43%, vanillin 0.23% and surplus; Said carase is a papain, be to utilize the white milk of immature papaya epidermis to refine the pure-natural biological enzyme (commercially available prod) that forms, during preparation, only need their uniform mixing are got final product together, prepare very simple, compatibility of the present invention is scientific and reasonable, easily produces, and cost is low, easy to use, effective, have no side effect, be the innovation on treatment beriberi, the tinea pedis medicine.

Four, the specific embodiment

Below in conjunction with embodiment the specific embodiment of the present invention is elaborated.

Embodiment 1: the present invention is in concrete enforcement, and can be realized by following mode: the present invention is made up of active aminoacids complex 60%, plant acid 35% and the carase 5% of weight percent meter, during preparation, with three kinds of component uniform mixing together.

Embodiment 2: the present invention in force also can be by weight percent meter: active aminoacids complex 50%, plant acid 45% and carase 5% are formed, during preparation, with their uniform mixing together.

Embodiment 3: the present invention in force, also can be specifically by weight percent meter: active aminoacids complex 55%, plant acid 42% and carase 3% are mixed and form together.

Embodiment 4: the present invention in force also can be by weight percent meter: active aminoacids complex 62%, plant acid 30% and carase 8% are formed, during preparation, with their mixings together.

Embodiment 5: the present invention also can be mixed by active aminoacids complex 60g, plant acid 35g and carase 5g and form.

The present invention has the function of granulation promoting, sterilization and drying, have very strong absorption and osmosis, nontoxic, have no side effect, be effective to treat beriberi, tinea pedis, also can be applicable to diseases such as rhagadia manus et pedis, slight dermatitis, comedo, inflammatory pimple, and use the therapeutic effect highly significant through clinical thousands of people, be that As the medicine took effect, the symptoms lessened, relevant clinical data following (is example with beriberi, tinea pedis):

One, selects the case standard

Fester between every foot toe, flowing water, with stench and pruritus, equal standards of selecting as case.

Two, diagnostic criteria

Beriberi, tinea pedis are referred to as beriberi, are due to foot's dermatophytosis infection, and clinical manifestation is dipping erosive type, vesicle type and squama keratinization type (being tinea pedis), and its diagnostic criteria is:

1, dipping erosive type, good sending out between the 4th, 5 or 3,4 toes shows as between toe and toe side skin dipping in the wrong turns white, and is the beancurd sheet shape, be easy to peel off, expose scarlet rotten to the corn face, companion's stench and pruritus, normal secondary infection causes erysipelas, lymphangitis, sees also have and send out the patient autumn and winter summer more;

2, vesicle type good is sent out in the palm sole of the foot, is referred to side, between toe and sufficient lateral margin, shows as gregariousness heavy wall vesicle, can be in the form of a ring or arcuation arrange, play is itched, secondary infection can form pustule, is mainly seen in summer;

3, squama keratinization type, comparatively see that good being sent out in autumn and winter season mainly involved the palm sole of the foot, referred to, between toe and veutro more, also can spread to hands, instep, show as dark red patch, xerosis cutis is coarse, and dermatoglyph obviously accompanies the desquamation skin to chap, the border is more clear, pruritus can be arranged, pain is arranged when chapping, the normal and vesicle type summer in winter alternately occurs.

Three, therapeutic scheme

With medicinal liquid of the present invention the patient is treated, soak once every day, during immersion, with medicinal liquid thin up of the present invention, the volume ratio of amount of water and medicinal liquid is 10: 1, and promptly per 100 ml waters add 10 milliliters of medicinal liquids, and soak time is each 20-30 minute, or sprinkling affected part, once a day, 2-3 days effective, can cure in general 7 days, add up curative effect after 7 days, check after 2 years.

Four, efficacy assessment standard

Cure: the symptom complete obiteration, and do not have recurrence in 2 years;

Effectively: symptom disappears substantially, or symptom obviously improves, and still need continue treatment;

Invalid: symptom does not have obvious improvement, need use the other drug treatment instead.

Five, statistical procedures

With medicinal liquid of the present invention 1580 people are treated, the lighter is sprayed the affected part once at every turn, and weight person is each to be soaked once, as follows to patient's statistical framework of 3-7 days of treatment:

Man 958 people, women 622 people, age 7-80 year, 7-16 year 246 people wherein, 17-60 year 1158 people, 176 people more than 60 years old cure 1264 people, account for 80% of sum, and effective 284 people account for 18% of sum, and invalid 32 people account for 2% of sum, and total effective rate reaches 98%.

Six, conclusion

Can see that by The above results medicinal liquid of the present invention is the active drug of treatment beriberi, tinea pedis, convenient, instant effect, cost is low, and acomia incumbent what side effect in treatment, drug safety, stable curative effect, curative effect is the creation on the pedopathy disease medicine up to 98%, and clinical meaning is huge.

Claims

1. treat beriberi for one kind, the medicinal liquid of tinea pedis, it is characterized in that, by weight percent meter: active aminoacids complex 50-70%, plant acid 25-45% is mixed with carase 3-8% and evenly forms together, and said active aminoacids complex is counted the active aminoacids complex of per 100 grams by aspartic acid 0.94 gram by weight, threonine 0.44 gram, glutamic acid 1.96 grams, glycine 1.4 grams, alanine 1.47 grams, cystine 0.56 gram, methionine 0.16 gram, isoleucine 0.72 gram, leucine 1.26 grams, tyrosine 0.12 gram, proline 1.82 grams, arginine 1.12 grams, histidine 0.08 gram, lysine 0.34 gram, phenylalanine 0.74 gram, valine 1.36 grams and surplus are formed for the water mixing; Said plant acid is a weight percent meter: acetic acid 15.6%, formic acid 11.1%, propanoic acid 0.63%, methanol 5.54%, acetone 1.7%, 2-Furan Aldehydes 2.1%, 2-cyclopentenone 0.2%, guaiacol 0.3%, paracresol 1.0%, be that water is formed to cresol 1.4%, orthoresol 1.2%, ethyl guaiacol 0.3%, furfural 0.5%, flavone 0.7%, maltol 0.43%, vanillin 0.23% and surplus; Said carase is a papain.

2. the medicinal liquid of treatment beriberi according to claim 1, tinea pedis is characterized in that, is made up of active aminoacids complex 60%, plant acid 35% and the carase 5% of weight percent meter, during preparation, with three kinds of component uniform mixing together.

3. the medicinal liquid of treatment beriberi according to claim 1, tinea pedis is characterized in that, by weight percent meter: active aminoacids complex 50%, plant acid 45% and carase 5% are formed, during preparation, with their uniform mixing together.

4. the medicinal liquid of treatment beriberi according to claim 1, tinea pedis is characterized in that, by weight percent meter: active aminoacids complex 55%, plant acid 42% and carase 3% are mixed and form together.

5. the medicinal liquid of treatment beriberi according to claim 1, tinea pedis is characterized in that, by weight percent meter: active aminoacids complex 62%, plant acid 30% and carase 8% are formed, during preparation, with their mixings together.